Page last updated: 2024-11-01

omeprazole and Cervical Fusion Syndrome

omeprazole has been researched along with Cervical Fusion Syndrome in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Omeprazole is an antagonist to the H+K+ ATPase of the gastric parietal cell."1.29Electrolyte disturbance with omeprazole therapy. ( Matthew, D; Melville, C; Milla, P; Shah, A, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melville, C1
Shah, A1
Matthew, D1
Milla, P1

Other Studies

1 other study available for omeprazole and Cervical Fusion Syndrome

ArticleYear
Electrolyte disturbance with omeprazole therapy.
    European journal of pediatrics, 1994, Volume: 153, Issue:1

    Topics: Child, Preschool; Esophagitis, Peptic; Humans; Klippel-Feil Syndrome; Male; Omeprazole; Potassium; S

1994